Send me a link:

*Text messaging rates may apply.

 Dow Up0.17% Nasdaq Up0.44%

Salix Pharmaceuticals Ltd. (SLXP)

-NasdaqGS
131.81 Down 2.03(1.52%) Jul 11, 4:00PM EDT
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingDec 31, 2013Dec 31, 2012Dec 31, 2011
Total Revenue 933,838   735,444   540,488  
Cost of Revenue179,392  124,597  95,369  
Gross Profit 754,446   610,847   445,119  
Operating Expenses
Research Development149,974  123,234  104,350  
Selling General and Administrative288,015  228,589  213,988  
Non Recurring -  41,600   -  
Others44,744  45,351  10,908  
Total Operating Expenses -  438,774   -  
Operating Income or Loss 271,713   172,073   115,873  
Income from Continuing Operations
Total Other Income/Expenses Net2,003  (4,727)2,349  
Earnings Before Interest And Taxes273,716  167,346  118,222  
Interest Expense61,651  55,518  32,121  
Income Before Tax212,065  111,828  86,101  
Income Tax Expense69,031  47,582  (1,298)
Minority Interest -   -   -  
Net Income From Continuing Ops143,034  48,666  87,399  
Non-recurring Events
Discontinued Operations -   -   -  
Extraordinary Items -   -   -  
Effect Of Accounting Changes -   -   -  
Other Items -   -   -  
Net Income 143,034   64,246   87,399  
Preferred Stock And Other Adjustments -   -   -  
Net Income Applicable To Common Shares 143,034   64,246   87,399  

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.